Fortress Biotech logo
Fortress Biotech FBIO
$ 1.61 2.54%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Fortress Biotech Financial Ratios 2011-2024 | FBIO

Annual Financial Ratios Fortress Biotech

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.3 -0.1 -2.6 -4.9 -3.2 -0.8 -2.5 -1.7 -2.4 -4.5 -2.2 -5.8 -1.3

P/S

0.2 0.1 2.5 5.0 3.5 2.4 0.9 5.7 135.5 - - - -

EPS

-8.5 -16.0 -0.8 -0.7 -0.7 -1.9 -1.6 -1.4 -1.2 -0.6 -1.2 -1.3 -5.5

EV (Enterprise Value)

101 M 70.7 M 35.6 M 128 M 147 M 120 M 179 M 93.4 M 53.1 M 59.9 M 2.25 M 138 M 29.9 M

EBITDA per Share

-17.3 -33.8 -2.28 -1.24 -1.94 -2.71 -2.38 -1.63 -1.07 -0.568 -1.18 -1.25 -4.39

EV/EBITDA

-0.2 -0.6 -0.8 -0.7 -1.2 -0.5 -0.8 -2.7 0.1 -4.9 -0.8

PEG

-0.0 -0.0 -0.17 -0.45 -0.05 0.04 0.15 0.05 0.03 -0.08 -0.56 -0.07 0.01

P/B

10.2 0.1 0.8 1.2 1.8 3.3 1.4 1.1 1.4 1.3 1.0 7.2 2.6

P/CF

-0.1 -0.0 -1.5 -2.5 -1.2 -0.6 -1.8 -1.7 -3.6 -5.6 -2.8 -6.8 -3.3

ROE %

-268.97 -207.51 -59.54 -23.62 -55.09 -426.21 -55.50 -66.41 -57.47 -28.91 -45.72 -125.31 -190.05

ROA %

-36.20 -29.42 -16.32 -14.15 -17.65 -59.68 -27.19 -32.27 -40.83 -22.82 -36.94 -67.35 -155.55

ROCE %

-631.40 -487.92 -173.49 -33.56 -61.29 -140.55 -56.69 -57.56 -46.77 -24.22 -40.03 -75.78 -176.26

Current Ratio

1.0 1.2 2.3 5.5 3.4 2.0 2.7 1.9 9.4 17.3 8.9 7.9 6.7

DSO

93.8 123.7 112.6 160.8 143.5 103.1 33.8 192.4 - - - - -

DIO

166.8 142.4 64.1 35.1 29.7 40.4 0.4 6.5 - - - - -

DPO

630.2 620.7 269.8 1017.3 1228.6 2039.0 82.3 781.4 - - - - -

Operating Cycle

260.6 266.1 176.7 196.0 173.2 143.5 34.2 199.0 - - - - -

Cash Conversion Cycle

-369.6 -354.6 -93.0 -821.3 -1055.4 -1895.5 -48.1 -582.4 - - - - -

All numbers in USD currency

Quarterly Financial Ratios Fortress Biotech

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.76 -0.73 -1.03 - -0.94 -3.65 -3.47 - -4.11 -0.26 -0.18 - -0.26 -0.04 -0.11 - -0.2 -0.19 -0.19 - -0.22 -0.24 0.03 -0.55 -0.37 -0.5 -0.49 -0.25 -0.67 -0.43 -0.3 -0.43 -0.32 -0.31 -0.31 -0.3 -0.46 -0.16 -0.31 -0.1 -0.13 -0.13 -0.21 -0.27 -0.24 -0.38 -0.35 -0.36 -0.24 -0.34 -0.35 -0.52 -0.48 -0.64 -4.71

EBITDA per Share

-1.12 -1.5 -2.11 - -1.78 -6.68 -8.54 - -8.38 -0.56 -0.54 - -0.61 -0.52 -0.36 - -0.29 -0.36 -0.33 - -0.39 -0.46 -0.66 -0.71 -0.62 -0.58 -0.8 -0.6 -0.78 -0.62 -0.46 -0.65 -0.42 -0.43 -0.39 -0.27 -0.46 -0.2 -0.33 -0.11 -0.12 -0.13 -0.18 -0.24 -0.23 -0.37 -0.34 -0.34 -0.24 -0.34 -0.35 -0.28 -0.5 -0.64 -1.21

ROE %

-150.92 -52.01 164.64 84.76 62.55 2.24 -167.62 -44.81 -54.59 -42.16 -29.13 -19.53 -35.03 -40.74 -52.59 -41.09 -89.77 -122.96 -159.66 -93.34 -1436.75 -2286.45 -3403.38 -4543.57 -3219.97 -2373.17 -1239.30 -127.21 -152.68 -134.82 -134.21 -143.12 -119.01 -117.24 -95.69 -85.19 -69.28 -43.85 -39.66 -28.91 -35.70 -38.82 -45.27 -45.72 -72.99 -90.29 -106.46 -125.31 -121.11 -111.76 -101.97 -190.05 -17.59 -19.51 -117.83

ROA %

-30.35 -23.58 -29.78 -25.23 -32.19 -35.80 -27.95 -16.69 -21.78 -19.92 -14.90 -8.20 -12.86 -12.43 -15.58 -12.42 -18.05 -19.03 -20.82 -10.81 -28.45 -34.62 -44.16 -59.68 -46.27 -45.49 -37.23 -27.19 -33.17 -29.74 -29.99 -32.27 -32.21 -39.92 -37.81 -40.83 -34.84 -24.67 -24.74 -22.82 -28.41 -31.05 -36.39 -36.94 -48.34 -55.03 -60.17 -67.35 -74.96 -74.88 -75.10 -155.55 -14.40 -15.97 -96.44

ROCE %

- - - - -50.06 -100.11 -134.59 -108.96 -132.45 -105.89 -88.67 -69.10 -92.07 -91.53 -99.59 -69.73 -155.71 -218.73 -289.89 -306.84 -2532.16 -3969.13 -5244.04 -6964.79 -4797.72 -3335.25 -2012.37 -203.60 -229.05 -213.19 -208.97 -213.04 -152.15 -139.36 -108.74 -90.41 -74.64 -48.86 -41.86 -29.08 -33.61 -36.78 -42.63 -43.70 -69.80 -87.04 -103.88 -123.34 -113.02 -105.01 -95.20 -183.17 -18.46 -19.53 -117.84

Current Ratio

0.9 0.9 1.0 1.0 0.9 0.9 1.1 1.2 1.5 1.7 1.9 2.3 2.1 2.5 2.7 2.4 2.4 2.4 2.5 1.5 1.5 1.5 1.5 1.2 1.2 1.2 1.2 2.0 2.0 2.0 2.0 1.9 1.9 1.9 1.9 3.5 3.5 3.5 3.5 4.8 4.8 4.8 4.8 5.2 5.2 5.2 5.2 2.2 2.2 2.2 2.2 5.5 5.5 5.5 5.5

DSO

65.9 62.1 87.6 - 32.5 116.4 204.9 - 157.9 144.6 103.5 - 125.3 116.7 170.8 - 230.4 208.8 116.2 - 126.4 133.6 134.1 55.8 97.0 73.6 102.5 13.1 12.6 14.0 8.0 17.3 338.3 74.9 126.5 - - - - - - - - - - - - - - - - - - - -

DIO

185.4 141.4 139.1 - 164.6 149.5 194.1 - 197.7 192.4 144.6 - 105.9 101.2 43.1 - 37.9 41.0 27.1 - 28.9 32.8 37.2 - 44.0 - 26.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

621.5 556.3 512.8 - 662.2 672.3 871.0 - 693.1 588.6 511.5 - 232.8 87.0 133.2 - 308.2 166.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

251.3 203.4 226.8 - 197.0 265.9 399.0 - 355.6 337.0 248.2 - 231.3 217.9 213.9 - 268.4 249.8 143.2 - 155.4 166.3 171.3 55.8 141.0 73.6 128.8 13.1 12.6 14.0 8.0 17.3 338.3 74.9 126.5 - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

-370.1 -352.9 -286.1 - -465.2 -406.5 -472.0 - -337.6 -251.6 -263.3 - -1.5 130.9 80.7 - -39.8 83.1 143.2 - 155.4 166.3 171.3 55.8 141.0 73.6 128.8 13.1 12.6 14.0 8.0 17.3 338.3 74.9 126.5 - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency